Prudential Financial
IPSC icon

Prudential Financial’s Century Therapeutics IPSC Stock Holding History

Prudential Financial’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.6K Sell
18,595
-6,705
-27% -$15.3K ﹤0.01% 2429
2026
Q1 		$57.2K Sell
25,300
-34,500
-58% -$72.5K ﹤0.01% 2298
2025
Q4 		$59.5K Hold
59,800
– – ﹤0.01% 2139
2025
Q3 		$29.8K Buy
59,800
+14,400
+32% +$7.76K ﹤0.01% 2385
2025
Q2 		$25.4K Buy
+45,400
New +$24.4K ﹤0.01% 2386
2025
Q1 		– Sell
-15,150
Closed -$15.3K – 2331
2024
Q4 		$15.3K Hold
15,150
– – ﹤0.01% 2277
2024
Q3 		$25.9K Hold
15,150
– – ﹤0.01% 2684
2024
Q2 		$38.6K Buy
15,150
+3,330
+28% +$10.5K ﹤0.01% 2639
2024
Q1 		$49.4K Buy
+11,820
New +$50K ﹤0.01% 2591

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Prudential Financial's IPSC Position: Q2 2026 in Review

Prudential Financial reduced its Century Therapeutics (IPSC) stake by 27% in Q2 2026, selling an estimated $15.3K and leaving 18,595 shares worth $45.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2429.

Prudential Financial first reported a position in IPSC in Q1 2024 and has held it in 9 quarters since. The position peaked at $59.5K in Q4 2025. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Prudential Financial held 18,595 shares of Century Therapeutics worth $45.6K as of Q2 2026.
  • Prudential Financial sold 6,705 Century Therapeutics shares in Q2 2026, an estimated $15.3K.
  • Century Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2429 holding.
  • Prudential Financial first reported a position in Century Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Prudential Financial's Century Therapeutics position peaked at $59.5K in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.